Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 61.15% |
| Q3 2025 | -44.74% |
| Q2 2025 | 3.87% |
| Q1 2025 | 8.35% |
| Q4 2024 | -6.24% |
| Q3 2024 | 5.12% |
| Q2 2024 | -7.65% |
| Q1 2024 | 17.13% |
| Q4 2023 | 15.29% |
| Q3 2023 | -14.21% |
| Q2 2023 | 8.06% |
| Q1 2023 | -12.02% |
| Q4 2022 | 25.56% |
| Q3 2022 | -20.81% |
| Q2 2022 | 4.95% |
| Q1 2022 | 39.08% |
| Q4 2021 | -4.70% |
| Q3 2021 | 29.04% |
| Q2 2021 | 17.94% |
| Q1 2021 | 44.33% |
| Q4 2020 | -0.71% |
| Q3 2020 | 3.03% |
| Q2 2020 | -2.79% |
| Q1 2020 | 0.00% |